Yungjin Pharm Co., Ltd.

South Korea Country flag South Korea
Sector: Pharmaceuticals
Ticker: 003520
ISIN: KR7003520004
Factsheet Factsheet

Levered/Unlevered Beta of Yungjin Pharm Co., Ltd. ( 003520 | KOR)

Beta is a statistical measure that compares the volatility of a stock against the volatility of the broader market, which is typically measured by a reference market index. Since the market is the benchmark, the market's beta is always 1. When a stock has a beta greater than 1, it means the stock is expected to increase by more than the market in up markets and decrease more than the market in down markets. Conversely, a stock with a beta lower than 1 is expected to rise less than the market when the market is moving up , but fall less than the market when the market is moving down. Despite being rare, a stock may have a negative beta, which means the stock moves opposite the general market trend.
Yungjin Pharm Co., Ltd. shows a Beta of 0.90.
This is slightly lower than 1. The volatility of Yungjin Pharm Co., Ltd. according to this measure is slightly lower than the market volatility.

Beta (Ref: KOSPI Composite)
Levered betaUnlevered beta
Yungjin Pharm Co., Ltd.Free trialFree trialFree trial
International PeersFree trialFree trialFree trial
KOSPI CompositeN/AN/AN/A
South Korea9.978.027.25
Stock Perf excl. Dividends (in KRW)
003520KOSPI CompositeRel. Perf.
International Peers - Yungjin Pharm Co., Ltd.
Company NameCtryMarket
last (mUSD)
Yungjin Pharm Co., Ltd.KOR816
International Peers Median0.66
Santen Pharmaceutical C...JPN5 886
Kaken Pharmaceutical Co...JPN2 005
Yunnan Baiyao Group Co....CHN19 263
Ono Pharmaceutical Co.,...JPN11 984
Humanwell Healthcare (G...CHN4 947
GPRV Analysis
GPRV® analysis is not available due to one of the
following reasons:
  • - Company is not covered by analysts (no estimates)
  • - Company is an insurance company
Net Sales Chart
Quotes Chart

1-Year Rebased Stock Chart

  • Yungjin Pharm Co., Ltd.
  • KOSPI Composite

Did you know ?

Infront Analytics' Beta calculator allows you to define your input parameters for custom beta calculations.
The beta calculator offers additional flexibility, such as:
- Reference index: apply the same reference index for all companies in your list regardless of their country.
- Sampling frequency: choose between a weekly or a monthly sampling frequency for the closing prices.
- Debt for unlevered beta: choose the type of debt to be used for unlevered beta calculations.
- Additional beta statistics: calculate R-squared and T-value.

About Beta

Standard beta is co-called levered, which means that it reflects the capital structure of the company (including the financial risk linked to the debt level). Unlevered beta (or ungeared beta) compares the risk of an unlevered company (i.e. with no debt in the capital structure) to the risk of the market. Unlevered beta is useful when comparing companies with different capital structures as it focuses on the equity risk. Unlevered beta is generally lower than the levered beta. However, unlevered beta could be higher than levered beta when the net debt is negative (meaning that the company has more cash than debt).
Many different betas can be calculated for a given stock. The main common variables that affect beta calculations are the time period, the reference date, the sampling frequency for closing prices and the reference index.
The calculation divides the covariance of the stock return with the market return by the variance of the market return. Beta is used very often for company valuation using the Discounted Cash Flows (DCF) method. The discount rate is calculated using the Weighted Average Cost of Capital (WACC). The WACC is essentially a blend of the cost of equity and the after-tax cost of debt. The cost of equity is usually calculated using the capital asset pricing model (CAPM), which defines the cost of equity as follows: re = rf + β × (rm - rf)
rf = Risk-free rate
β = Beta (levered)
(rm - rf) = Market risk premium.